Honestly this is not a good option. Think Twice

Discussion in 'Alder Biopharmaceuticals' started by anonymous, Sep 2, 2019 at 9:35 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    100 percent agree! The medication will make some noise. Chance to be part of a growing company which in itself will present unique opportunities. Sure it’s a risk, but this whole industry right now is a risk. Good people getting laid off weekly from the big players
     

  2. anonymous

    anonymous Guest

    Who else is on the fence? The above comment sounds like someone in recruiting.
     
  3. anonymous

    anonymous Guest

    Huge advantages for whom? Management or the reps? How much equity is on the table? Thats the question
     
  4. 10 Calls per Day

    10 Calls per Day new user

    Joined:
    Sep 20, 2019
    Messages:
    2
    Likes Received:
    0
    Because you should always trust CafePharma. The best of the best in the industry.
     
  5. anonymous

    anonymous Guest

    Yet here you are. There is more truth on these boards than you will get from management or recruiters.
     
  6. anonymous

    anonymous Guest

    Now that it’s under Lundbeck, you won’t see huge dollars or any equity. That ship just sailed.
     
  7. anonymous

    anonymous Guest

    Even better, 3 injections 4 days a year with Ajovy.